SCM
Superstring Capital Management’s UroGen Pharma URGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Sell |
87,912
-335,720
| -79% | -$4.6M | 1.43% | 22 |
|
|
2025
Q1 | $4.69M | Buy |
423,632
+122,426
| +41% | +$1.35M | 5.57% | 6 |
|
|
2024
Q4 | $3.21M | Buy |
+301,206
| New | +$3.21M | 2.78% | 10 |
|
|
2024
Q2 | – | Sell |
-288,267
| Closed | -$4.32M | – | 56 |
|
|
2024
Q1 | $4.32M | Buy |
288,267
+32,837
| +13% | +$493K | 2.86% | 13 |
|
|
2023
Q4 | $3.83M | Buy |
+255,430
| New | +$3.83M | 2.73% | 12 |
|